Polymorphisms in the serotonin receptor gene HTR2A are associated with quantitative traits in panic disorder-Reference-Cited by-同舟云学术

Polymorphisms in the serotonin receptor gene HTR2A are associated with quantitative traits in panic disorder

Published:2007 Issue:4 Volume:144B Page:424-429
ISSN:1552-4841
Container-title:American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
language:en
Short-container-title:Am. J. Med. Genet.

Author:

Unschuld Paul G.,Ising Marcus,Erhardt Angelika,Lucae Susanne,Kloiber Stefan,Kohli Martin,Salyakina Daria,Welt Tobias,Kern Nikola,Lieb Roselind,Uhr Manfred,Binder Elisabeth B.,Müller-Myhsok Bertram,Holsboer Florian,Keck Martin E.

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Psychiatry and Mental health,Genetics (clinical)

Reference43 articles.

1. Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs

2. Temperament and personality features in patients with major depression, panic disorder and mixed conditions

3. Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale

4. Haploview: analysis and visualization of LD and haplotype maps

5. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hereditary Patterns and Genetic Associations in Obsessive-Compulsive Disorder (OCD): Neuropsychiatric Insights, Genetic Influences, and Treatment Perspectives;Current Gene Therapy;2024-08-30

2. Neurotransmitter Gene Polymorphisms Are Associated with Symptom Clusters in Patients Undergoing Radiation Therapy;Seminars in Oncology Nursing;2023-08

3. Association of GABRG3, GABRB3, HTR2A gene variants with autism spectrum disorder;Gene;2023-06

4. Biological and cognitive theories explaining panic disorder: A narrative review;Frontiers in Psychiatry;2023-01-30

5. The role of pharmacogenetics in the treatment of anxiety disorders and the future potential for targeted therapeutics;Expert Opinion on Drug Metabolism & Toxicology;2021-10-15